Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(2.12)
# 2,950
Out of 4,981 analysts
346
Total ratings
40.97%
Success rate
-6.27%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $65 → $80 | $55.89 | +43.14% | 5 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $72 → $75 | $77.53 | -3.26% | 37 | Aug 6, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $50 → $65 | $64.04 | +1.50% | 5 | Jul 31, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $4.36 | +221.10% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $34.39 | +190.78% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $16.15 | +178.64% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $33.86 | +121.50% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $12.47 | +140.58% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $18.60 | +136.56% | 14 | Jul 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $17.91 | -44.17% | 14 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 → $10 | $13.34 | -25.04% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $11.42 | +162.70% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $23.80 | +425.21% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $11.05 | +35.75% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.16 | +331.03% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $4.15 | +20.48% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.09 | +139.23% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $5.18 | +189.58% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $20.07 | +124.27% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $2.71 | +10.70% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $9.90 | +304.04% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.59 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.89 | +270.37% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $2.02 | +48.51% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.52 | +285.88% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.50 | +1,683.24% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $6.74 | +122.72% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.38 | - | 12 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40,000 → $610,000 | $1.07 | +57,009,245.79% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $6.83 | - | 4 | Jun 2, 2023 |
CRISPR Therapeutics AG
Aug 7, 2025
Maintains: Buy
Price Target: $65 → $80
Current: $55.89
Upside: +43.14%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $77.53
Upside: -3.26%
Ionis Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $64.04
Upside: +1.50%
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $4.36
Upside: +221.10%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $34.39
Upside: +190.78%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $16.15
Upside: +178.64%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $33.86
Upside: +121.50%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $12.47
Upside: +140.58%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $18.60
Upside: +136.56%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $17.91
Upside: -44.17%
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $13.34
Upside: -25.04%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $11.42
Upside: +162.70%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $23.80
Upside: +425.21%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $11.05
Upside: +35.75%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.16
Upside: +331.03%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $4.15
Upside: +20.48%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $2.09
Upside: +139.23%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $5.18
Upside: +189.58%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $20.07
Upside: +124.27%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $2.71
Upside: +10.70%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $9.90
Upside: +304.04%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.59
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.89
Upside: +270.37%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $2.02
Upside: +48.51%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.52
Upside: +285.88%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $0.50
Upside: +1,683.24%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $6.74
Upside: +122.72%
Dec 16, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.38
Upside: -
Sep 6, 2023
Maintains: Buy
Price Target: $40,000 → $610,000
Current: $1.07
Upside: +57,009,245.79%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $6.83
Upside: -